About ALSF

Study IDs Potential Treatment For Children with Relapsed Leukemia

 » View all news titles
 » View titles this week
» View titles this month

Columbia University Medical Center Newsroom

01/24/2018

Most children with acute lymphoblastic leukemia (ALL) can be cured, but the prognosis is dismal for about 20 percent of patients who relapse after treatment.

Now a new study from researchers at Columbia University’s Herbert Irving Comprehensive Cancer Center has found that a mutation that leads to relapse in many ALL patients also causes a weakness that could be exploited to kill the cancer cells in patients experiencing relapse.

>>Read more